Skip to main content
Toggle menu
Home
pharma-stocks
pharma-stocks
A surfer without a degree is worth $16 billion after his biotech company's stock soared 1,100% in a year
Thu, 09/26/2024 - 05:39
Tech Insider
Bob Duggan is the CEO of Summit Therapeutics.
Summit Therapeutics
finance
,
health
,
trending-uk
,
finance
,
Tech
,
bob-duggan
,
summit-therapeutics
Subscribe to pharma-stocks
sfy39587stp18